News Posts List
UCB files BRIVIACT® (brivaracetam) CV in the U.S. as monotherapy treatment for adult epilepsy patient
01/19/2017
Brussels (Belgium), Atlanta (Georgia, USA), 19 January 2017 – 18:30 (CET): UCB has today announced the filing of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for BRIVIACT® (brivaracetam) CV as monotherapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy within the U.S.
Flow MedTech Announces Vice President of Medical Affairs (VPMA)
01/09/2017
DALLAS, TX — JANUARY 9, 2017 — Flow MedTech — Today Flow MedTech, Inc., an early-stage company developing an implantable medical device to prevent strokes in people with irregular heart rhythms, announces the appointment of Senthil Thambidorai, MD, FHRS, as Vice President of Medical Affairs.
Athenahealth to Add 500 Jobs in Atlanta, Double Footprint
01/04/2017
Healthcare tech company Athenahealth (Nasdaq: ATHN) will add about 500 jobs in Atlanta.
Zika Vaccine Developer Names New Chief Scientific Officer
01/03/2017
A Smyrna-based developer of vaccines against Zika, Ebola, HIV and other infectious diseases has named a new chief scientific officer.
Excellence in Biotech Education Awarded at 2016 BIO International Convention
05/30/2016
WASHINGTON--(BUSINESS WIRE)--The BioGENEius Challenges and Leadership Awards are organized by the Biotechnology Institute, a U.S. based organization dedicated to biotechnology education, and will be announced during the 2016 BIO International Convention, which is being held June 6-9 in San Francisco. Generous support from sponsors include Johnson & Johnson Innovation and the Biotechnology Innovation Organization.
News Feed